Air travel and pneumothorax

Xiaowen Hu, Clayton T. Cowl, Misbah Baqir, Jay H Ryu

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The number of medical emergencies onboard aircraft is increasing as commercial air traffic increases and the general population ages, becomes more mobile, and includes individuals with serious medical conditions. Travelers with respiratory diseases are at particular risk for in-flight events because exposure to lower atmospheric pressure in a pressurized cabin at cruising altitude may result in not only hypoxemia but also pneumothorax due to gas expansion within enclosed pulmonary parenchymal spaces based on Boyle's law. Risks of pneumothorax during air travel pertain particularly to those patients with cystic lung diseases, recent pneumothorax or thoracic surgery, and chronic pneumothorax. Currently available guidelines are admittedly based on sparse data and include recommendations to delay air travel for 1 to 3 weeks after thoracic surgery or resolution of the pneumothorax. One of these guidelines declares existing pneumothorax to be an absolute contraindication to air travel although there are reports of uneventful air travel for those with chronic stable pneumothorax. In this article, we review the available data regarding pneumothorax and air travel that consist mostly of case reports and retrospective surveys. There is clearly a need for additional data that will inform decisions regarding air travel for patients at risk for pneumothorax, including those with recent thoracic surgery and transthoracic needle biopsy.

Original languageEnglish (US)
Pages (from-to)688-694
Number of pages7
JournalChest
Volume145
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Air Travel
Pneumothorax
Thoracic Surgery
Guidelines
Atmospheric Pressure
Aircraft
Needle Biopsy
Emergencies
Gases
Air

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Hu, X., Cowl, C. T., Baqir, M., & Ryu, J. H. (2014). Air travel and pneumothorax. Chest, 145(4), 688-694. https://doi.org/10.1378/chest.13-2363

Air travel and pneumothorax. / Hu, Xiaowen; Cowl, Clayton T.; Baqir, Misbah; Ryu, Jay H.

In: Chest, Vol. 145, No. 4, 2014, p. 688-694.

Research output: Contribution to journalArticle

Hu, X, Cowl, CT, Baqir, M & Ryu, JH 2014, 'Air travel and pneumothorax', Chest, vol. 145, no. 4, pp. 688-694. https://doi.org/10.1378/chest.13-2363
Hu, Xiaowen ; Cowl, Clayton T. ; Baqir, Misbah ; Ryu, Jay H. / Air travel and pneumothorax. In: Chest. 2014 ; Vol. 145, No. 4. pp. 688-694.
@article{85757fdf1471415e820cd224b3545828,
title = "Air travel and pneumothorax",
abstract = "The number of medical emergencies onboard aircraft is increasing as commercial air traffic increases and the general population ages, becomes more mobile, and includes individuals with serious medical conditions. Travelers with respiratory diseases are at particular risk for in-flight events because exposure to lower atmospheric pressure in a pressurized cabin at cruising altitude may result in not only hypoxemia but also pneumothorax due to gas expansion within enclosed pulmonary parenchymal spaces based on Boyle's law. Risks of pneumothorax during air travel pertain particularly to those patients with cystic lung diseases, recent pneumothorax or thoracic surgery, and chronic pneumothorax. Currently available guidelines are admittedly based on sparse data and include recommendations to delay air travel for 1 to 3 weeks after thoracic surgery or resolution of the pneumothorax. One of these guidelines declares existing pneumothorax to be an absolute contraindication to air travel although there are reports of uneventful air travel for those with chronic stable pneumothorax. In this article, we review the available data regarding pneumothorax and air travel that consist mostly of case reports and retrospective surveys. There is clearly a need for additional data that will inform decisions regarding air travel for patients at risk for pneumothorax, including those with recent thoracic surgery and transthoracic needle biopsy.",
author = "Xiaowen Hu and Cowl, {Clayton T.} and Misbah Baqir and Ryu, {Jay H}",
year = "2014",
doi = "10.1378/chest.13-2363",
language = "English (US)",
volume = "145",
pages = "688--694",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - Air travel and pneumothorax

AU - Hu, Xiaowen

AU - Cowl, Clayton T.

AU - Baqir, Misbah

AU - Ryu, Jay H

PY - 2014

Y1 - 2014

N2 - The number of medical emergencies onboard aircraft is increasing as commercial air traffic increases and the general population ages, becomes more mobile, and includes individuals with serious medical conditions. Travelers with respiratory diseases are at particular risk for in-flight events because exposure to lower atmospheric pressure in a pressurized cabin at cruising altitude may result in not only hypoxemia but also pneumothorax due to gas expansion within enclosed pulmonary parenchymal spaces based on Boyle's law. Risks of pneumothorax during air travel pertain particularly to those patients with cystic lung diseases, recent pneumothorax or thoracic surgery, and chronic pneumothorax. Currently available guidelines are admittedly based on sparse data and include recommendations to delay air travel for 1 to 3 weeks after thoracic surgery or resolution of the pneumothorax. One of these guidelines declares existing pneumothorax to be an absolute contraindication to air travel although there are reports of uneventful air travel for those with chronic stable pneumothorax. In this article, we review the available data regarding pneumothorax and air travel that consist mostly of case reports and retrospective surveys. There is clearly a need for additional data that will inform decisions regarding air travel for patients at risk for pneumothorax, including those with recent thoracic surgery and transthoracic needle biopsy.

AB - The number of medical emergencies onboard aircraft is increasing as commercial air traffic increases and the general population ages, becomes more mobile, and includes individuals with serious medical conditions. Travelers with respiratory diseases are at particular risk for in-flight events because exposure to lower atmospheric pressure in a pressurized cabin at cruising altitude may result in not only hypoxemia but also pneumothorax due to gas expansion within enclosed pulmonary parenchymal spaces based on Boyle's law. Risks of pneumothorax during air travel pertain particularly to those patients with cystic lung diseases, recent pneumothorax or thoracic surgery, and chronic pneumothorax. Currently available guidelines are admittedly based on sparse data and include recommendations to delay air travel for 1 to 3 weeks after thoracic surgery or resolution of the pneumothorax. One of these guidelines declares existing pneumothorax to be an absolute contraindication to air travel although there are reports of uneventful air travel for those with chronic stable pneumothorax. In this article, we review the available data regarding pneumothorax and air travel that consist mostly of case reports and retrospective surveys. There is clearly a need for additional data that will inform decisions regarding air travel for patients at risk for pneumothorax, including those with recent thoracic surgery and transthoracic needle biopsy.

UR - http://www.scopus.com/inward/record.url?scp=84898736823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898736823&partnerID=8YFLogxK

U2 - 10.1378/chest.13-2363

DO - 10.1378/chest.13-2363

M3 - Article

C2 - 24687705

AN - SCOPUS:84898736823

VL - 145

SP - 688

EP - 694

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -